Cargando…

Effects of Selected Anionic β-Cyclodextrins on Persistence of Blood Glucose Lowering by Insulin Glargine after Subcutaneous Injection to Rats

Insulin glargine is a synthetic long-acting insulin product used for patients with diabetes mellitus. In this study, to obtain the further desirable blood-glucose lowering profile of insulin glargine, we investigated the effects of β-cyclodextrin sulfate (Sul-β-CyD) and sulfobutylether β-cyclodextri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Uehata, Keiko, Anno, Takayuki, Hayashida, Kayoko, Motoyama, Keiichi, Higashi, Taishi, Hirayama, Fumitoshi, Ono, Naomi, Pipkin, James D., Uekama, Kaneto, Arima, Hidetoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236511/ https://www.ncbi.nlm.nih.gov/pubmed/22187651 http://dx.doi.org/10.1155/2011/195146

Ejemplares similares

In Vitro Gene Delivery Mediated by Asialofetuin-Appended Cationic Liposomes Associated with γ-Cyclodextrin into Hepatocytes
por: Motoyama, Keiichi, et al.
Publicado: (2011)

Preparation and evaluation of cyclodextrin polypseudorotaxane with PEGylated liposome as a sustained release drug carrier
por: Hayashida, Kayoko, et al.
Publicado: (2014)

Potential Use of Polyamidoamine Dendrimer Conjugates with Cyclodextrins as Novel Carriers for siRNA
por: Arima, Hidetoshi, et al.
Publicado: (2011)

Polyamidoamine Dendrimer Conjugates with Cyclodextrins as Novel Carriers for DNA, shRNA and siRNA
por: Arima, Hidetoshi, et al.
Publicado: (2012)

Potential use of Folate-appended Methyl-β-Cyclodextrin as an Anticancer Agent
por: Onodera, Risako, et al.
Publicado: (2013)

Induction of mitophagy-mediated antitumor activity with folate-appended methyl-β-cyclodextrin
por: Kameyama, Kazuhisa, et al.
Publicado: (2017)

Involvement of Autophagy in Antitumor Activity of Folate-appended Methyl-β-cyclodextrin
por: Onodera, Risako, et al.
Publicado: (2014)

Recent Findings Concerning PAMAM Dendrimer Conjugates with Cyclodextrins as Carriers of DNA and RNA
por: Arima, Hidetoshi, et al.
Publicado: (2009)

Nanoparticles of folic acid‐methyl‐β‐cyclodextrin (FA‐MβCD)/adamantane‐albumin exhibit enhanced antitumor activity compared with FA‐MβCD alone
por: Sakai, Aiko, et al.
Publicado: (2022)

Synthesis of multi-lactose-appended β-cyclodextrin and its cholesterol-lowering effects in Niemann–Pick type C disease-like HepG2 cells
por: Motoyama, Keiichi, et al.
Publicado: (2017)

Cholesterol lowering effects of mono-lactose-appended β-cyclodextrin in Niemann–Pick type C disease-like HepG2 cells
por: Motoyama, Keiichi, et al.
Publicado: (2015)

Differential Effects of 2-Hydroxypropyl-Cyclodextrins on Lipid Accumulation in Npc1-Null Cells
por: Hoque, Sanzana, et al.
Publicado: (2020)

2-Hydroxypropyl-β-Cyclodextrin Acts as a Novel Anticancer Agent
por: Yokoo, Masako, et al.
Publicado: (2015)

Influence of Npc1 genotype on the toxicity of hydroxypropyl-β-cyclodextrin, a potentially therapeutic agent, in Niemann–Pick Type C disease models()
por: Tanaka, Yuta, et al.
Publicado: (2014)

In vivo Efficacy and Safety Evaluation of Lactosyl-β-cyclodextrin as a Therapeutic Agent for Hepatomegaly in Niemann-Pick Type C Disease
por: Maeda, Yuki, et al.
Publicado: (2019)

Folic Acid-Appended Hydroxypropyl-β-Cyclodextrin Exhibits Potent Antitumor Activity in Chronic Myeloid Leukemia Cells via Autophagic Cell Death
por: Hoshiko, Toshimi, et al.
Publicado: (2021)

In Vitro and In Vivo Evaluation of 6-O-α-Maltosyl-β-Cyclodextrin as a Potential Therapeutic Agent Against Niemann-Pick Disease Type C
por: Yasmin, Nushrat, et al.
Publicado: (2019)

Intracerebroventricular Treatment with 2-Hydroxypropyl-β-Cyclodextrin Decreased Cerebellar and Hepatic Glycoprotein Nonmetastatic Melanoma Protein B (GPNMB) Expression in Niemann–Pick Disease Type C Model Mice
por: Fukaura, Madoka, et al.
Publicado: (2021)

Twenty Years of Research on Cyclodextrin Conjugates with PAMAM Dendrimers
por: Arima, Hidetoshi
Publicado: (2021)

Different solubilizing ability of cyclodextrin derivatives for cholesterol in Niemann–Pick disease type C treatment
por: Yamada, Yusei, et al.
Publicado: (2023)

A clue to unprecedented strategy to HIV eradication: “Lock-in and apoptosis”
por: Tateishi, Hiroshi, et al.
Publicado: (2017)

Hypersensitivity reaction associated with subcutaneous glargine insulin therapy in a cat
por: Murphy, Lisa A, et al.
Publicado: (2016)

Supramolecular polymer-based transformable material for reversible PEGylation of protein drugs
por: Utatsu, Kosei, et al.
Publicado: (2021)

Aggregation versus inclusion complexes to solubilize drugs with cyclodextrins. A case study using sulphobutylether-β-cyclodextrins and remdesivir
por: Piñeiro, Ángel, et al.
Publicado: (2021)

Synthesis of Randomly Substituted Anionic Cyclodextrins in Ball Milling
por: Jicsinszky, László, et al.
Publicado: (2017)

Identification of candidate molecular targets of the novel antineoplastic antimitotic NP-10
por: Yokoyama, Takuya, et al.
Publicado: (2019)

Design and Evaluation of An Extended-Release Olmesartan Tablet Using Chitosan/Cyclodextrin Composites
por: Anraku, Makoto, et al.
Publicado: (2019)

Hydroxypropyl-β-cyclodextrin Enhances Oral Absorption of Silymarin Nanoparticles Prepared Using PureNano™ Continuous Crystallizer
por: Onodera, Risako, et al.
Publicado: (2022)

Metabolism of Insulin Glargine After Repeated Daily Subcutaneous Injections in Subjects With Type 2 Diabetes
por: Lucidi, Paola, et al.
Publicado: (2012)

Plasma Exposure to Insulin Glargine and Its Metabolites M1 and M2 After Subcutaneous Injection of Therapeutic and Supratherapeutic Doses of Glargine in Subjects With Type 1 Diabetes
por: Bolli, Geremia B., et al.
Publicado: (2012)

DAMP-Inducing Adjuvant and PAMP Adjuvants Parallelly Enhance Protective Type-2 and Type-1 Immune Responses to Influenza Split Vaccination
por: Hayashi, Tomoya, et al.
Publicado: (2018)

CD Oxyanions as a Tool for Synthesis of Highly Anionic Cyclodextrin Polymers †
por: Girek, Tomasz, et al.
Publicado: (2020)

Fasting impairs type 2 helper T cell infiltration in the lung of an eosinophilic asthma mouse model
por: Suzuki, Yusuke, et al.
Publicado: (2021)

Versatile delivery platform for nucleic acids, negatively charged protein drugs, and genome-editing ribonucleoproteins using a multi-step transformable polyrotaxane
por: Taharabaru, Toru, et al.
Publicado: (2023)

Insulin glargine overdose
por: Doğan, Fatma Sarı, et al.
Publicado: (2012)

Equipotency of insulin glargine 300 and 100 U/mL with intravenous dosing but differential bioavailability with subcutaneous dosing in dogs
por: Werner, Ulrich, et al.
Publicado: (2020)

Enhancement of α-Mangostin Wound Healing Ability by Complexation with 2-Hydroxypropyl-β-Cyclodextrin in Hydrogel Formulation
por: Wathoni, Nasrul, et al.
Publicado: (2020)

Duration of action of two insulin glargine products, LY2963016 insulin glargine and Lantus insulin glargine, in subjects with type 1 diabetes mellitus
por: Linnebjerg, Helle, et al.
Publicado: (2016)

A Tunable Porous β-Cyclodextrin Polymer Platform to Understand and Improve Anionic PFAS Removal
por: Wang, Ri, et al.
Publicado: (2022)

Insulin glargine and the risk of cancer
por: Ahmed, FA
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_u71ib9homs3sn6fc4t3nolqn99